Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Peripartum Cardiomyopathy

By afschroeder • April 18, 2026

Jain H, Patel N, Jain J, Baqal O, DeSimone CV, Goldsweig AM, Joly JM, Mentz RJ, Fonarow GC, Sharma G. Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Peripartum Cardiomyopathy. JACC Adv. 2026 Apr 1:102712. doi: 10.1016/j.jacadv.2026.102712. Epub ahead of print. PMID: 41989376.

Tags: Cardiology/Epi, Guideline-directed medical therapy, heart failure, Peripartum cardiomyopathy, Publications, SGLT2I, sodium glucose co-transporter 2 inhibitors

Biodegradable devices for transcatheter patent foramen ovale closure: current evidence and future directions

Khan A, Khan M, Thyagaturu H, Shafi N, Muhibullah F, Kanwal K, Irshad K, Fonarow GC, Sattar Y. Biodegradable devices for transcatheter patent foramen ovale[...]

Shielded by Scar?: Transvenous Lead Extraction Outcomes After Prior Sternotomy

Lin CP, Boyle NG. Shielded by Scar?: Transvenous Lead Extraction Outcomes After Prior Sternotomy. JACC Clin Electrophysiol. 2026 Apr 6:S2405-500X(26)00256-2. doi: 10.1016/j.jacep.2026.03.013. Epub ahead of[...]

Measuring nephron number in the healthy and diabetic rat kidney in vivo using MRI without contrast agents

Baldelomar EJ, Charlton JR, Keilhoz S, Kohn B, Wilson LD, Xiong LI, Garfinkel A, Bennett KM. Measuring nephron number in the healthy and diabetic rat[...]